Ivan Mikaélian

Université Claude Bernard Lyon 1 — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

24h-index2.1kcitations89works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PI3K/AKT/mTOR signaling in cancer(11), Genomics, phytochemicals, and oxidative stress(10), Endoplasmic Reticulum Stress and Disease(9), Mechanisms of cancer metastasis(8), Cell death mechanisms and regulation(7)

Publications89 total

The endoplasmic reticulum pool of Bcl-xL prevents cell death through IP3R-dependent calcium release
Cell Death Discovery·2024· 10 citedOpen Access
Viruses traverse the human proteome through peptide interfaces that can be biomimetically leveraged for drug discovery
Proceedings of the National Academy of Sciences·2024· 2 citedOpen Access
Nrh L11R single nucleotide polymorphism, a new prediction biomarker in breast cancer, impacts endoplasmic reticulum-dependent Ca2+ traffic and response to neoadjuvant chemotherapy
Cell Death and Disease·2023· 6 citedOpen Access
Mitochondrial Bcl-xL promotes brain synaptogenesis by controlling non-lethal caspase activation
iScience·2023· 4 citedOpen Access
Figure S1 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Figures S8 & S9 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Supplementary Movie S1 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Supplementary Movie S1 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Figure S7 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Figures S2 & S3 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Figure S7 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Data from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Supplementary Material & Methods, tables, movie legend from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Supplementary Material & Methods, tables, movie legend from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Figure S5 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Figure S4 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Figure S4 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Figure S6 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Data from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
Figure S5 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Ruth Rimokh(21), Germain Gillet(18), Philippe Gonzalo(16), Rudy Gadet(15), Alain Sergeant(9), Nikolay Popgeorgiev(9), Isabelle Treilleux(7), Cédric Hesling(7), Jonathan Lopez(7), Évelyne Manet(5), Laurent Fattet(5), Mathieu Deygas(5), Adrien Nougarède(5), Benoı̂t de Chassey(5), Olivier Marcillat(5), Anà Hennino(5), Philippe Bertolino(5), Monique Buisson(4), Stéphane Borel(4), Alain Puisieux(3)